Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Laropiprant

🥰Excellent
Catalog No. T15712Cas No. 571170-77-9
Alias MK-0524

Laropiprant (MK-0524) is a potent and selective antagonist of prostaglandin D2 (PGD2) receptor (DP) such as and DP/DP1 receptor(Ki = 0.57 nM) and TP Receptor(Ki = 2.95 nM).

Laropiprant

Laropiprant

🥰Excellent
Purity: 99.97%
Catalog No. T15712Alias MK-0524Cas No. 571170-77-9
Laropiprant (MK-0524) is a potent and selective antagonist of prostaglandin D2 (PGD2) receptor (DP) such as and DP/DP1 receptor(Ki = 0.57 nM) and TP Receptor(Ki = 2.95 nM).
Pack SizePriceAvailabilityQuantity
1 mg$32In Stock
5 mg$79In Stock
10 mg$115In Stock
25 mg$231In Stock
50 mg$355In Stock
100 mg$507In Stock
200 mg$693In Stock
1 mL x 10 mM (in DMSO)$87In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Laropiprant"

Select Batch
Purity:99.97%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Laropiprant (MK-0524) is a potent and selective antagonist of prostaglandin D2 (PGD2) receptor (DP) such as and DP/DP1 receptor(Ki = 0.57 nM) and TP Receptor(Ki = 2.95 nM).
Targets&IC50
DP/DP1 receptor:0.57 nM (ki), TP receptor:2.95 nM (ki)
In vitro
Laropiprant blocks DP receptor-dependent enhance in VASP phosphorylation, as well as inhibition of P-selectin expression, GPIIb/IIIa activation, and in vitro thrombus formation. Laropiprant antagonizes the increased platelet aggregation by TP and EP3 receptor activation. Laropiprant (1 μM) induces a significant inhibition of the aggregation but still counteracts the pronounced inhibition caused by PGD2 (30 nM) and BW245c (3 nM). Laropiprant (10 μM) and niacin inhibit in vitro thrombus formation[2].
AliasMK-0524
Chemical Properties
Molecular Weight435.9
FormulaC21H19ClFNO4S
Cas No.571170-77-9
SmilesCS(=O)(=O)c1cc(F)cc2c3CC[C@H](CC(O)=O)c3n(Cc3ccc(Cl)cc3)c12
Relative Density.1.486 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 100 mg/mL (229.41 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.2941 mL11.4705 mL22.9410 mL114.7052 mL
5 mM0.4588 mL2.2941 mL4.5882 mL22.9410 mL
10 mM0.2294 mL1.1471 mL2.2941 mL11.4705 mL
20 mM0.1147 mL0.5735 mL1.1471 mL5.7353 mL
50 mM0.0459 mL0.2294 mL0.4588 mL2.2941 mL
100 mM0.0229 mL0.1147 mL0.2294 mL1.1471 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Laropiprant | purchase Laropiprant | Laropiprant cost | order Laropiprant | Laropiprant chemical structure | Laropiprant in vitro | Laropiprant formula | Laropiprant molecular weight